Biofrontera
Manufacturing · Germany · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Hemmelrather Weg 201, Leverkusen, Nordrh...Phone Number
+49 21487632Website
www.biofrontera.comRevenue
$27.9 MillionStock Symbol
B8FK.DEIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Biofrontera
Biofrontera is headquartered in Leverkusen, Germany and specializes in the development and sale of dermatological drugs and medical cosmetics. Biofrontera was founded in 1997 and develops and markets innovative products for the care, protection and treatment of the skin.Explore more
Biofrontera Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Biofrontera your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Biofrontera launches new products
Website visits: Recent activity has been detected on your website
Biofrontera, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Biofrontera is spiking on competitors!
Check if Biofrontera has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Biofrontera
Earning: See what the market has to say on Biofrontera recently announced quarterly report
Click to see if Biofrontera had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Biofrontera has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Biofrontera as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Biofrontera is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Biofrontera is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Biofrontera.
Biofrontera financials insights
Gather financial insights about Biofrontera, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Share Placement
$29.9M
Stock Offering
$18M
Biofrontera Tech Stack
Most Recent Scoops
Project
Biofrontera has submitted AMAluce for FDA approval for the treatment of basal cell carcinoma, with a PDUFA date of September 28 of this year. This indication is currently approved for AMAluce in the EU but has not yet received FDA clearance.
Pharmaceuticals
Project
Biofrontera has completed a phase two study on moderate to severe acne using photodynamic therapy and plans to request an FDA meeting in the second half of the year to discuss the design of a phase three program for this indication.
Medical Research, Pharmaceuticals
Earnings
Biofrontera has reported an adjusted EBITDA loss of $3.6 million for Q1 2026, improving by $0.8 million compared to an adjusted EBITDA loss of $4.4 million in Q1 2025. The company expects to reach general break-even or at least cash flow break-even for the full year 2026.
Earnings, Forecasting, Finance, Financial Operations
Project
Biofrontera has completed a phase three trial to obtain FDA approval for AMAluce for the treatment of actinic keratosis on the upper extremities, with an FDA submission planned for September. This submission aims to address a current gap in the company's label relative to its US competitor, which already holds approval for this body area.
Pharmaceuticals, Clinical Operations
Project
Healthcare Technology, Regulations
Biofrontera News & Media
Biofrontera Inc. (BFRI) Q3 2023 Earnings Call Transcript
Biofrontera Inc. (NASDAQ:NASDAQ:BFRI) Q3 2023 Earnings Conference Call November 10, 2023 10:00 AM ETCompany ParticipantsTirth Patel - IRHermann Luebbert -...Biofrontera Inc. (BFRI) Q2 2023 Earnings Call Transcript
Biofrontera Inc. (NASDAQ:NASDAQ:BFRI) Q2 2023 Earnings Conference Call August 11, 2023 8:30 AM ETCompany ParticipantsTirth Patel - Investor RelationsHermann Luebbert - Executive Chairman...Biofrontera Inc. (BFRI) Q1 2023 Earnings Call Transcript
Biofrontera Inc. (NASDAQ:NASDAQ:BFRI) Q1 2023 Earnings Conference Call May 12, 2023 8:30 AM ETCompany ParticipantsTirth Patel - Investor RelationsHermann Luebbert - Executive Chairman and...Biofrontera, Inc. (BFRI) Q4 2022 Earnings Call Transcript
Biofrontera, Inc. (NASDAQ:NASDAQ:BFRI) Q4 2022 Earnings Conference Call March 8, 2023 4:30 PM ETCompany ParticipantsErica Monaco - CEO, COO, Treasurer & SecretaryFred Leffler -...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Biofrontera
Sign Up For FreeTo access detailed company insights
Biofrontera is headquartered in Leverkusen, Germany and specializes in the development and sale of dermatological drugs and medical cosmetics. Biofrontera was founded in 1997 and develops and markets innovative products for the care, protection and treatment of the skin.... Read More
